|
|
Article: Hemispherx Biopharma to Present New Interim Clinical Data Regarding Phase IIB Study in HIV/AIDS at the 16th International Conference on Antiviral Research.
- Article from:
- PR Newswire
- Article date:
- March 6, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Hemispherx Biopharma Inc. , a leading company in the experimental-stage development of immune based therapies primarily addressing the diseases of HIV/AIDS and Chronic Fatigue Syndrome, announced today that the Company will be giving an oral presentation of its new interim clinical data regarding its Phase IIb Trial for HIV/AIDS (labeled Structured Treatment Interruption) at the 16th International Conference on Antiviral Research on Monday, April 28, 2003 at 11:15 am, EST, at the Savannah Marriott Riverfront Hotel in Savannah, Georgia (April 27-May 1, 2003).
Dr. William M. Mitchell, M.D., PhD. will present the abstract entitled "A Phase IIB Prospective, ...